Marina Del Ray, CA, United States of America

Elliott S Klein


Average Co-Inventor Count = 5.4

ph-index = 10

Forward Citations = 774(Granted Patents)


Location History:

  • Marina Del Rey, CA (US) (1998 - 2003)
  • Marina del Ray, CA (US) (2003 - 2005)

Company Filing History:


Years Active: 1998-2005

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovator Elliott S. Klein: Pioneering Research in Retinoid Modulation

Introduction

Elliott S. Klein, based in Marina Del Rey, California, is a distinguished inventor with a remarkable portfolio of 11 patents. His groundbreaking research primarily focuses on nuclear receptors and retinoid compounds that hold significant therapeutic potential.

Latest Patents

Among his recent innovations, Klein has developed methods for identifying compounds with nuclear receptor negative hormone and antagonist activities. These patents detail techniques for characterizing and synthesizing modulators that can influence retinoid nuclear receptor transactivation activity. Notably, his findings highlight the synthesis and applications of various aryl-substituted compounds exhibiting biological activities akin to negative hormones and antagonists. Klein’s inventions also propose strategies for administering RAR antagonists, aiming to mitigate side effects associated with retinoids and vitamin A. His research offers pathways for potentiating the activities of other retinoids and nuclear receptor agonists, showcasing the innovative therapeutic applications of his work.

Career Highlights

Klein has made significant contributions to the field while working with reputable organizations such as Allergan, Inc. and Allergan Sales, Inc. His career reflects a strong commitment to advancing the understanding of nuclear receptor mechanisms and their implications for human health.

Collaborations

Throughout his career, Elliott S. Klein has collaborated with esteemed colleagues, including Roshantha A. Chandraratna and Sunil Nagpal. These partnerships have enabled the exploration of innovative ideas and the development of effective research methodologies in the realm of retinoid biology.

Conclusion

Elliott S. Klein stands out as a pivotal figure in innovation within the biopharmaceutical landscape. His extensive research on nuclear receptors and retinoid compounds not only enhances scientific understanding but also opens up new avenues for therapeutic advancements. With a total of 11 patents to his name, Klein continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…